Full Text
PCN89 Cost Effectiveness of Treatment With New 6-Month Leuprorelin Acetate Formulation in Patients With Advanced Prostate Cancer

Abstract

Authors

N.L. Tundia M. Fuldeore D. Gruca S. Hass P. Bacher A. Bodhani

Back to Volume 15, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×